Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer
- Title
- Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer
- Author
- 백승삼
- Keywords
- APAF-1; Early; Recurrence; Colorectal cancer
- Issue Date
- 2016-08
- Publisher
- Springer Nature
- Citation
- Langenbeck's Archives of Surgery, v. 401, Page. 1203-1210
- Abstract
- Purpose Apoptotic protease activating factor-1 (APAF-1) is a key regulator in the mitochondrial apoptotic pathway and an important diagnostic and therapeutic biomarker. Loss of APAF-1 expression has been observed in various tumors including colorectal cancer. The aim of our study was to evaluate the relationship between loss of APAF-1 expression and early recurrence of stage I–III colorectal cancer. Methods We investigated 165 out of 492 patients who had undergone curative resection for colorectal cancer between 1991 and 2001. Sixty-one patients (37.0 %) had early recurrence within 1 year after surgery. Tissue microarrays were used for immunohistochemical detection of APAF-1. Results The mean age of patients with recurrence was 58 years (range, 24–85); 88 (53.3 %, 88/165) were male. APAF-1 was expressed in 32 (19.4 %, 32/165) cases and was not expressed in 133 (80.6 %, 133/165). In univariate analysis, early recurrence significantly correlated with loss of APAF-1 expression (p = 0.017), tumor stage (p = 0.005), N category (p = 0.001), and lymphatic invasion (p = 0.008). In a logistic regression model, loss of APAF-1 expression (p = 0.015, 95 % CI = 1.280–10.063) and N category (p = 0.001, 95 %
CI = 0.004–0.739) proved to be independent risk factors associated with early recurrence. In patients with lymph node metastasis, early recurrence was more frequent in the APAF-1- negative group than in the APAF-1-positive group (46.2 % (54/117) vs. 22.2 % (6/27), p = 0.023). Conclusions Loss of APAF-1 expression is associated with early recurrence in stage I–III colorectal cancer, suggesting that APAF-1 may have clinical value as a predictive marker of early recurrence.
- URI
- https://link.springer.com/article/10.1007%2Fs00423-016-1483-3https://repository.hanyang.ac.kr/handle/20.500.11754/76237
- ISSN
- 1435-2443; 1435-2451
- DOI
- 10.1007/s00423-016-1483-3
- Appears in Collections:
- COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML